| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
FR:CS
AXA SA
|
Oct 29, 2026 | BUY |
Strong Buy
+8.8% avg upside
19 analysts
|
$52.50
23.26% Upside
|
+10.6% | Β· |
|
DE:MUV2
Munich Reinsurance
|
Oct 23, 2026 | HOLD |
Buy
-15.5% avg upside
17 analysts
|
$550.00
3.01% Downside
|
+6.1% | Β· |
|
GB:MLHL
Malibu Life Holdings
|
Oct 16, 2026 | BUY |
Strong Buy
+62.4% avg upside
1 analyst
|
$20.50
62.44% Upside
|
Β· | Β· |
|
CH:ZURN
Zurich Insurance Group
|
Oct 15, 2026 | HOLD |
Hold
-3.6% avg upside
16 analysts
|
$620.00
0.99% Downside
|
+7.4% | Β· |
|
CH:SREN
Swiss Re AG
|
Oct 14, 2026 | SELL |
Sell
-20.6% avg upside
15 analysts
|
$110.00
28.22% Downside
|
-2.2% | Β· |
|
DE:ALV
Allianz
|
Oct 12, 2026 | HOLD |
Buy
-13.3% avg upside
23 analysts
|
$440.00
0.27% Upside
|
+12.7% | Β· |
|
GB:0NO0
Storebrand ASA
|
Oct 06, 2026 | BUY |
Buy
+2.4% avg upside
3 analysts
|
$224.00
15.56% Upside
|
Β· | Β· |
|
IL:MMHD
Menora Miv Hld
|
Sep 30, 2026 | BUY |
Strong Buy
+21.5% avg upside
1 analyst
|
$60000.00
21.48% Upside
|
-5.4% | Β· |
|
IT:G
Assicurazioni Generali S.p.A.
|
Sep 29, 2026 | HOLD |
Hold
-10.4% avg upside
16 analysts
|
$38.00
10.44% Downside
|
+4.0% | Β· |
|
DE:HNR1
Hannover Rueck
|
Sep 09, 2026 | BUY |
Buy
-7.8% avg upside
16 analysts
|
$325.00
12.07% Upside
|
+20.3% | Β· |
|
HK:1299
AIA Group
|
Sep 07, 2026 | BUY |
Strong Buy
+43.4% avg upside
9 analysts
|
$114.00
51.14% Upside
|
+1.8% | Β· |
|
FR:SCR
SCOR
|
Jul 31, 2026 | HOLD |
Buy
-3.1% avg upside
12 analysts
|
$36.00
4.16% Upside
|
+4.9% | Β· |
|
IL:HARL
Harel
|
Sep 25, 2025 | HOLD |
Buy
-29.4% avg upside
2 analysts
|
$10500.00
41.82% Downside
|
+88.0% | Β· |
|
GB:PRU
Prudential
|
Sep 22, 2025 | BUY |
Strong Buy
+812.3% avg upside
24 analysts
|
$1350.00
46.45% Upside
|
-7.4% | Β· |
|
IL:PHOE
Phoenix
|
Jul 28, 2025 | BUY |
Strong Buy
-11.9% avg upside
1 analyst
|
$15000.00
11.86% Downside
|
+44.7% | Β· |
|
GB:HSX
Hiscox
|
Jun 08, 2025 | BUY |
Strong Buy
+272.7% avg upside
15 analysts
|
$1500.00
20.23% Downside
|
+30.3% | Β· |
|
GB:0R78
Tryg A/S
|
Apr 14, 2025 | BUY |
Buy
+4.6% avg upside
10 analysts
|
$180.00
12.89% Upside
|
+7.3% | Β· |
|
GB:0OJC
Gjensidige Forsikring ASA
|
Feb 23, 2025 | SELL |
Sell
-8.4% avg upside
12 analysts
|
$185.00
29.24% Downside
|
-24.2% | Β· |
|
GB:CRE
Conduit Holdings Ltd
|
Feb 23, 2025 | BUY |
Buy
+16.6% avg upside
6 analysts
|
$600.00
36.90% Upside
|
+9.7% | Β· |
|
GB:0HAG
Sampo Plc
|
Feb 23, 2025 | HOLD |
Buy
+102.7% avg upside
15 analysts
|
$6.80
28.27% Downside
|
+19.1% | Β· |
|
GB:LGEN
Legal & General
|
Dec 10, 2024 | HOLD |
Hold
+445.5% avg upside
17 analysts
|
$230.00
24.19% Downside
|
+4.4% | Β· |
|
GB:MNG
M&G Plc
|
Dec 10, 2024 | BUY |
Buy
-5.7% avg upside
14 analysts
|
$215.00
32.73% Downside
|
+36.6% | Β· |
|
GB:SBRE
Sabre Insurance Group plc
|
Dec 10, 2024 | HOLD |
Buy
+8.5% avg upside
7 analysts
|
$145.00
15.71% Downside
|
-10.2% | Β· |
|
GB:BPM
B.P. Marsh & Partners plc
|
Jul 03, 2024 | BUY |
Strong Buy
-11.3% avg upside
1 analyst
|
$625.00
11.34% Downside
|
+36.9% | Β· |
|
GB:HUW
Helios Underwriting
|
Dec 19, 2023 | HOLD |
Hold
-34.7% avg upside
1 analyst
|
$170.00
34.70% Downside
|
+55.1% | Β· |
|
GB:AV
Aviva plc
|
Feb 23, 2023 | HOLD |
Buy
-7.6% avg upside
17 analysts
|
$445.00
39.43% Downside
|
+3.0% | Β· |
|
MURGY
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft Unsponsored ADR
|
Apr 08, 2020 | BUY |
Buy
5 analysts
|
β | +62.7% | Β· |
|
ARZGY
Assicurazioni Generali
|
Mar 16, 2020 | HOLD |
Sell
-40.8% avg upside
2 analysts
|
$14.01
40.80% Downside
|
+62.8% | Β· |
|
NL:AGN
Aegon NV
|
Aug 15, 2019 | HOLD |
Buy
-6.6% avg upside
11 analysts
|
$4.80
34.99% Downside
|
-26.9% | Β· |
|
SCRYY
SCOR SE
|
Sep 10, 2018 | HOLD |
Hold
1 analyst
|
β | -1.4% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.